Back to Search
Start Over
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
- Source :
- Annals of Oncology; April 2006, Vol. 17 Issue: 4 p563-570, 8p
- Publication Year :
- 2006
-
Abstract
- Background:This randomized phase III trial was designed to demonstrate the superiority of autologous peptide-loaded dendritic cell (DC) vaccination over standard dacarbazine (DTIC) chemotherapy in stage IV melanoma patients.
Details
- Language :
- English
- ISSN :
- 09237534 and 15698041
- Volume :
- 17
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- Annals of Oncology
- Publication Type :
- Periodical
- Accession number :
- ejs53416152
- Full Text :
- https://doi.org/10.1093/annonc/mdj138